1. Short title This Act may be cited as the Second Look at Drug Patents Act of 2019 . 2. Amendments (a) In general Section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) is amended— (1) in subsection (b)(1), at the end of the fifth sentence, by inserting subject to subsection (j)(7)(A)(iii)(II) before the period; and (2) in subsection (j)(7)(A)(iii)— (A) by striking When patent and inserting (I) When patent ; (B) by inserting , subject to subclauses (II) and (III), after , include